Skip to content
  • Sunday, 26 July 2026
  • 2:57 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 23, 2026 0

The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, promising faster,…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 16, 2026 0

The World Health Organization (WHO) has unveiled a groundbreaking set of new recommendations designed to fundamentally transform tuberculosis (TB) diagnostics,…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu May 8, 2026 0

The global fight against tuberculosis (TB), a persistent and devastating infectious disease, has reached a critical juncture with the World…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 1, 2026 0

The World Health Organization (WHO) has unveiled groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, aiming for faster, more…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 24, 2026 0

The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, emphasizing speed,…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 17, 2026 0

The global landscape of tuberculosis (TB) diagnostics is undergoing a significant transformation following new recommendations issued by the World Health…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States

Reynand Amr Wu Apr 9, 2026 0

The global fight against tuberculosis (TB) has reached a pivotal juncture, with the World Health Organization (WHO) unveiling transformative new…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu Apr 1, 2026 0

The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…

Read More
Unlocking Photosynthetic Efficiency: Hornworts Offer a Molecular Blueprint for Supercharged CropsNovartis Navigates Generics Storm in Q1, Eyes Robust Future Fueled by Strategic Acquisitions and Pipeline AdvancementsBreakthrough in Topological Photonics as Researchers Observe Quantized Drift of Light for the First TimeWhat’s coming up at ASMS 2026?
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ